Speaking of Medicine – Mid-Year OPDP Enforcement Review
Eye on FDA
AUGUST 2, 2022
The 4 letters issued this calendar year: Involved 3 Untitled Letters and 1 Warning Letter – a profile not out of proportion given that about 33 percent of letters issued since 2004 have been Warning Letters. The characterization of investigative data resulted in a violation related to promotion of an unapproved compound.
Let's personalize your content